Title |
Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma
|
Institution |
WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY
|
Principal Investigator |
MELNICK, ARI
|
NCI Program Director |
Lin
|
Cancer Activity |
Comp Min Biomed Prog
|
Division |
CRCHD
|
Funded Amount |
$113,565
|
Project Dates |
08/06/2014 - 07/31/2019
|
Fiscal Year |
2017
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Chemotherapy (100.0%)
|
Non Hodgkins Lymphoma (100.0%)
|
Research Type |
Cancer Initiation: Alterations in Chromosomes
Systemic Therapies - Discovery and Development
|
Abstract |
No abstract available. |